Health and pharmaceutical research
Patient, provider and access research for health systems, insurers, pharmaceutical companies and health programmes.
Commissioned by: Health ministries, insurers, pharmaceutical and diagnostics companies, health NGOs.
Questions we answer
- ?Where do patients actually go first, and why not to us?
- ?What drives adherence, and where does it break down?
- ?How do prescribers choose between equivalent products?
- ?What does out-of-pocket cost do to treatment decisions?
- ?Is the health intervention changing behaviour, or only awareness?
What we measure
- ·Care-seeking pathways and first point of contact
- ·Treatment adherence and drop-off points
- ·Prescriber and pharmacist decision drivers
- ·Out-of-pocket cost and insurance coverage effects
- ·Programme baseline and impact measurement
How we field it
Modes are chosen by what the question needs, not by what is cheapest. Read the method.
What you receive
Care pathway and adherence findings with the drop-off points located and sized.
With the dataset, the cross-tabulations and the method statement. The data is yours outright.
Where we field
54 African markets, to ward level where the administrative geography allows it. Kenya is mapped to all 47 counties, 290 constituencies and 1,450 wards.
Start with a scoping call.
Thirty minutes to fix what the study has to answer, the markets it covers and what it will cost. Nothing goes to field before you sign off the design.
Request a scoping call